Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Open Label, Single-Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)

Next Previous
Trial Profile

A Multicenter, Open Label, Single-Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Jul 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AP 101 (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions
  • Sponsors AL-S Pharma

Most Recent Events

  • 22 Apr 2021 Results assessing safety, tolerability, and pharmacokinetics of AP-101 after intravenous administration in familial and sporadic amyotrophic lateral sclerosis, presented at the 73rd Annual Meeting of the American Academy of Neurology.
  • 26 Oct 2020 Planned End Date changed from 1 Oct 2020 to 2 Nov 2020.
  • 26 Oct 2020 Planned primary completion date changed from 1 Aug 2020 to 2 Nov 2020.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top